2015
DOI: 10.1007/s00535-015-1038-3
|View full text |Cite
|
Sign up to set email alerts
|

Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective

Abstract: Low-dose aspirin, alone or combined with other antiplatelet agents, is increasingly prescribed for cardiovascular prevention. However, the cardiovascular benefits should be evaluated together with the gastrointestinal risks. Low-dose aspirin is associated with upper and lower gastrointestinal injury, although lower gastrointestinal effects are poorly characterized. This gastrointestinal risk differs among antiplatelets drugs users. The most important risk factors are history of peptic ulcer, older age, and con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
28
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(31 citation statements)
references
References 107 publications
(129 reference statements)
2
28
0
1
Order By: Relevance
“…The most important outcome associated with GIB is the low adherence or even discontinuation of DAPT therapy . In the current study, a discontinuation rate of 2.91% was observed.…”
Section: Discussionsupporting
confidence: 42%
“…The most important outcome associated with GIB is the low adherence or even discontinuation of DAPT therapy . In the current study, a discontinuation rate of 2.91% was observed.…”
Section: Discussionsupporting
confidence: 42%
“…Therapy-induced senescence is an effective therapeutic strategy for malignant tumors (Ewald et al, 2010), but its clinical induction may injure the surrounding normal tissue. Since aspirin is associated with upper and lower gastrointestinal (GI) damage (Sostres et al, 2013;Lanas and Gargallo, 2015), we questioned whether such adverse effects would be present in the normal colonic epithelium following senescence-inducing aspirin treatment. Accordingly, we examined the effect of aspirin (500 mM for 72 hours) on normal colonic epithelial cells (HCoEpiC).…”
Section: Resultsmentioning
confidence: 99%
“…The risk of ibuprofen-induced gastrointestinal bleeding is higher in patients who take more than one type of NSAID simultaneously (because of a synergistic effect) and/or platelet antiaggregants/anticoagulants [35]. Other predisposing factors are a positive history of peptic ulcer or gastrointestinal bleeding, Helicobacter pylori infection, diverticulosis or chronic inflammatory bowel disease.…”
Section: Safety and Tolerability Of Ibuprofenmentioning
confidence: 99%